Patents Assigned to Tandem Diabetes Care, Inc.
  • Patent number: 11676694
    Abstract: Apparatuses and methods for training users of ambulatory medical devices. The methods relate to improving user interactions with the touchscreens of devices. In one embodiment there is an operating mode that records all user interactions along with various device parameters and allows the clinician to review the patient's performance for the initial use period. Automated analysis software may be employed to analyze the data generated by the device. The results of the analysis may be used by the clinician to improve the patient and device interaction.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: June 13, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Geoffrey A. Kruse, Kim Blickenstaff, Michael J. Rosinko
  • Patent number: 11654236
    Abstract: Disclosed herein are systems and methods for mitigating the risk of insulin stacking in automated insulin delivery systems. In AID systems configured to both automatically calculate insulin delivery based on glucose levels and receive manual programming of meal boluses configured to counteract carbohydrates in a meal, insulin stacking can result if the system automatically increases insulin delivery based on a rise in glucose levels in response to consumption of a meal and the user later programs a meal bolus for the meal. The risk of such double dosing is mitigated by the systems and methods disclosed herein by enabling the system to account for recent automated insulin increases when a meal bolus is programmed.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: May 23, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jacob Kearns, Michael Michaud, Geoffrey A. Kruse, Thomas R. Ulrich, Paul Harris, Scott Leas, Betsy Dokken, Garrett Marin, Nicholas Sherer
  • Patent number: 11638781
    Abstract: An infusion pump system providing therapy to a patient in a closed-loop or semi-closed loop mode can safely automatically revert to open-loop therapy. The system stores a default open-loop basal rate profile in memory. The system also continually tracks the insulin on board for the patient over a plurality of closed-loop therapy intervals. When an error or event occurs requiring reversion to open-loop therapy, the system automatically provides therapy according to the open-loop basal rate profile and the tracked insulin on board amount.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: May 2, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael J. Rosinko
  • Patent number: 11607492
    Abstract: A portable insulin pump can integrate and display data from a continuous glucose monitor (CGM) to allow a user to more readily determine whether any interaction with the pump is necessary. Data from the CGM can automatically be transmitted to the pump and can be displayed for user analysis or automatically analyzed to present recommendations to the user based on combined data from the CGM and the pump.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: March 21, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Rosinko, Sean Saint, Jason Farnan, Shaun Buchanan
  • Patent number: 11596731
    Abstract: A device for infusing liquid medicaments such as insulin includes an infusion pump. The device can modify a medicament delivery protocol stored in memory to delivery an alternative medicament delivery protocol with the pump.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: March 7, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Sean Saint
  • Patent number: 11580918
    Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a bistable display. A display element of the bistable display is placed in one of two stable orientations upon application of a biasing voltage and stays in the stable orientation when the biasing voltage is removed. The processor includes a display module configured to display a non-blank reversion display screen on the bistable display when no input is received at the user interface after a specified time duration, and to recurrently change the reversion display screen until input is received at the user interface.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: February 14, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Patent number: 11576594
    Abstract: An apparatus including a controller can determine a rate of change of a blood glucose level of a subject from blood glucose data and determine if there is a risk of the blood glucose level going high or low.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: February 14, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Blomquist
  • Patent number: 11484642
    Abstract: An ambulatory infusion pump can include a maximum bolus override procedure. When a bolus amount greater than a maximum bolus amount is requested, the pump can provide an alert indicating that the amount requested exceeds the maximum bolus amount. If the user confirms the request in response to the alert, the bolus amount can be delivered to the user. The amount delivered in response to the confirmation can be a first portion of the bolus amount. A reminder can then be provided that a second portion of the bolus amount that is a remaining portion of the requested bolus amount was also requested. If a second confirmation is received in response to the alert, the second portion of the bolus amount can also delivered to the user.
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: November 1, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: John Walsh
  • Patent number: 11488549
    Abstract: An apparatus comprising a pump configured to deliver insulin, a processor, and a user interface including a color display. Color on the display can be used to bring a user's attention to a change in status of the device or a detected change in status of the patient.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: November 1, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Timothy B. Bresina, Gail Beth Bynum, Michael D. Welsch
  • Patent number: 11464901
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to be paired with a remote control device that can include a remote consumer electronic device such as a smartphone and/or a dedicated remote controller.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: October 11, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jason Farnan, Zion Greenlee, Geoffrey A. Kruse, Michael Michaud
  • Patent number: 11464908
    Abstract: Disclosed herein are apparatuses and methods for improved use of infusion sites for infusion pumps. Apparatuses and methods for delivery of medicaments such as insulin disclosed herein can increase the effectiveness of therapy by more accurately determining when an infusion site is no longer absorbing insulin at an acceptable rate as well as determining the effectiveness of different infusion sites on the body with respect to each other and over time.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: October 11, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Geoffrey A. Kruse
  • Patent number: 11470069
    Abstract: Systems and methods for controlling a peripheral device with a web browser. A system includes a peripheral device and a user computing device executing a web browser and a device manager, the device manager configured to operate the peripheral device and including a device manager web server. An authentication token can be passed to the web browser from a web server upon coupling of the peripheral device with the user computing device and login by the user with the web browser. The web browser can pass the authentication token to the device manager through the device manager web server. The device manager can transmit the authentication token to the web server to pair the web browser with the device manager.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: October 11, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Robert Windsor Gillespie
  • Patent number: 11458246
    Abstract: Disclosed herein are systems and methods for monitoring performance of an ambulatory infusion pump. An ambulatory infusion pump can include a reservoir configured to contain a medicament including a plunger at a proximal end of the reservoir and an outlet port at a distal end of the reservoir. A motor can be configured to cause linear motion of a pushrod to contact and move the plunger to cause medicament to flow from the reservoir out of the outlet port to a patient. An optical encoder can be employed to monitor a linear position of the pushrod. In addition, the optical encoder can be employed to monitor additional system conditions and/or a secondary encoder can be employed to monitor the performance of the optical encoder.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: October 4, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Alexander Seitz, Michael Michaud, Philip Sven Lamb, Justin Brown, Geoffrey A. Kruse
  • Patent number: 11383027
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: July 12, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Sean Saint
  • Patent number: 11364340
    Abstract: A simplified insulin pump allows type II diabetics to identify routine patterns in their daily lifestyle that provide a generally accurate typical pattern of activity and meals. An infusion regimen can be programmed into the pump that generally correlates with this typical pattern to provide a viable treatment option for a type II diabetic without the need for specific and precise matching of insulin to carbohydrate consumption or activity level.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: June 21, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Mike Rosinko
  • Patent number: 11324898
    Abstract: A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: May 10, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Rosinko
  • Patent number: 11305057
    Abstract: Embodiments of the present disclosure enable a user-wearable infusion pump that may have a limited user interface including no display to execute and provide feedback on a number of functions. A remote control device having a display can be used to control the infusion pump. The infusion pump can include one or more indicator lights that can be indicate different statuses with different light patterns. The remote control device can include a display screen that provides further information relating to various pump statuses.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: April 19, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Michaud, Geoffrey A. Kruse, Jason Farnan, Ian Cadieux, Anthony Elbancol, Preston Sobel, David Nguyen, Robert Eastridge, Kennen Dietz, Caleb Butler
  • Patent number: 11302433
    Abstract: An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: April 12, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael L. Blomquist, Kevin Kopp, Thomas Alan Savard
  • Patent number: 11298053
    Abstract: An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: April 12, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Michael Blomquist
  • Patent number: D980232
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: March 7, 2023
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Jason Farnan, Shaun Buchanan, Zion Greenlee